U.S. Markets close in 2 hrs 47 mins

Pfizer Inc. (PFE)

New York Stock Exchange Consolidated Issue - Nasdaq Real Time Price. Currency in USD
Add to watchlist
33.09+0.33 (+1.01%)
As of 1:13PM EDT. Market open.
People also watch
MRKJNJJPMINTCGE
Full screen
Previous Close32.76
Open32.76
Bid33.10 x 8500
Ask33.11 x 6000
Day's Range32.70 - 33.19
52 Week Range29.83 - 35.38
Volume6,233,438
Avg. Volume18,425,887
Market Cap197.48B
Beta1.05
PE Ratio (TTM)27.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.92%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • Immunomedics' Progress in Phase II Cancer Study Encouraging
    Zacks2 hours ago

    Immunomedics' Progress in Phase II Cancer Study Encouraging

    Immunomedics, Inc. (IMMU) announced encouraging interim results from a phase II study on its cancer candidate, labetuzumab govitecan. Shares were up 7% on Monday in response.

  • Reuters3 hours ago

    India grants Pfizer patent on pneumonia vaccine in blow to aid group

    India has granted Pfizer Inc a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026.

  • 3 High-Yield Pharmaceutical Stocks
    Motley Fool7 hours ago

    3 High-Yield Pharmaceutical Stocks

    Pfizer, GlaxoSmithKline, and Novo Nordisk all offer up temptingly high yields. Here's why they're worth putting on your radar.